Download
s00066-021-01747-8.pdf 213,06KB
WeightNameValue
1000 Titel
  • Vulnerabilitäten bei Radiomics: Warum die populärste Radiomics-Signatur unbemerkt das Tumorvolumen gemessen hat
1000 Titelzusatz
  • Vulnerabilities of radiomics: Why the most popular radiomics signature accidentally measured tumor volume
1000 Autor/in
  1. Putz, Florian |
  2. Fietkau, Rainer |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-02-03
1000 Erschienen in
1000 Quellenangabe
  • 197(4):361-364
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00066-021-01747-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987598/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Single-isocenter dynamic conformal arc (SIDCA) therapy is a technically efficient way of delivering stereotactic radiosurgery (SRS) to multiple metastases simultaneously. This study reports on the safety and feasibility of linear accelerator (LINAC) based SRS with SIDCA for patients with multiple brain metastases.!##!Methods!#!All patients who received SRS with this technique between November 2017 and June 2019 within a prospective registry trial were included. The patients were irradiated with a dedicated planning tool for multiple brain metastases using a LINAC with a 5 mm multileaf collimator. Follow-up was performed every 3 months, including clinical and radiological examination with cranial magnetic resonance imaging (MRI). These early data were analyzed using descriptive statistics and the Kaplan-Meier method.!##!Results!#!A total of 65 patients with 254 lesions (range 2-12) were included in this analysis. Median beam-on time was 23 min. The median follow-up at the time of analysis was 13 months (95% CI 11.1-14.9). Median overall survival and median intracranial progression-free survival was 15 months (95% CI 7.7-22.3) and 7 months (95% CI 3.9-10.0), respectively. Intracranial and local control after 1 year was 64.6 and 97.5%, respectively. During follow-up, CTCAE grade I adverse effects (AE) were experienced by 29 patients (44.6%; 18 of them therapy related, 27.7%), CTCAE grade II AEs by four patients (6.2%; one of them therapy related, 1.5%), and CTCAE grade III by three patients (4.6%; none of them therapy related). Two lesions (0.8%) in two patients (3.1%) were histopathologically proven to be radiation necrosis.!##!Conclusion!#!Simultaneous SRS using SIDCA seems to be a feasible and safe treatment for patients with multiple brain metastases.
1000 Sacherschließung
lokal Tomography, X-Ray Computed [MeSH]
lokal ROC Curve [MeSH]
lokal Humans [MeSH]
lokal Literatur Kommentiert
lokal Tumor Burden [MeSH]
lokal Oncology
lokal Radiotherapy
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-3966-2872|https://frl.publisso.de/adhoc/uri/RmlldGthdSwgUmFpbmVy
1000 Hinweis
  • DeepGreen-ID: 7b05e0638d93441f916f28f1b93aa591 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6448685.rdf
1000 Erstellt am 2023-05-04T10:03:37.007+0200
1000 Erstellt von 322
1000 beschreibt frl:6448685
1000 Zuletzt bearbeitet Fri Oct 13 23:46:24 CEST 2023
1000 Objekt bearb. Fri Oct 13 23:46:24 CEST 2023
1000 Vgl. frl:6448685
1000 Oai Id
  1. oai:frl.publisso.de:frl:6448685 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source